SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?


To: Ibexx who wrote (1131)12/31/1998 3:33:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 1580
 
Celebrex and Vioxx cost 10-20 times as much as Ibuprofen. Both companies (MRK and PFE/MTC) would like a different label. Approval was expect. Companies had hoped for a safer label.